Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (9): 14-20.doi: 10.6040/j.issn.1671-7554.0.2020.090

Previous Articles     Next Articles

Perioperative observation and postoperative risk factors of severe hypocalcemia after parathyroidectomy: a report of 303 cases

ZHANG Hongbin1,2, ZHAO Hanhui2, WANG Suxia2, ZHOU Peng3, HE Qingqing3, WANG Yanqun4, DING Weiping5, LIU Gang1   

  1. 1. Department of Nephrology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Nephrology Research Institute of Shandong University, Jinan 250033, Shandong, China;
    2. Department of Blood Purification, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan 250031, Shandong, China;
    3. Department of Thyroid and Breast, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan 250031, Shandong, China;
    4. Department of Laboratory, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan 250031, Shandong, China;
    5. Department of Nuclear Medicine, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan 250031, Shandong, China
  • Online:2020-09-10 Published:2020-08-30

PDF (PC)

216

Abstract: Objective To investigate the perioperative safety and efficacy of parathyroidectomy(PTX)in the treatment of refractory secondary hyperparathyroidism(SHPT)and risk factors of postoperative severe hypocalcemia. Methods Atotal of 303 patients with refractory SHPT who underwent PTX in the 960th Hospital of the PLA Joint Logistics Support Force during Nov. 2010 and Dec. 2018 were involved. The preoperative and postoperative blood parathyroid hormone(iPTH), serum calcium, phosphorus and alkaline phosphatase were collected and statistically analyzed, and the postoperative complications and prognosis were observed. Univariate and multivariate analyses were performed for patients with severe hypocalcemia to determine the risk factors. Results A total of 1 216 parathyroid glands were resected in the 303 cases. The cure rate and success rate were both 99%. Symptoms of bone pain and itching were relieved in 284 cases on the day of operation, and in 19 cases 1 week after operation. On day-1 after operation, iPTH ［25.65(16.00, 43.20)pg/mL］, serum phosphorus ［1.43(1.01, 1.94)mmol/L］ and serum calcium ［2.04(1.76, 2.29)mmol/L］ were significantly lower than those before operation(P<0.001). Hypocalcemia occurred in 171 cases(56.44%)after operation, severe hypocalcemia in 106 cases(34.98%), subcutaneous hemorrhage and hematoma in 10 cases(3.3%), hypotension shock in 2 cases(0.6%), subcutaneous emphysema in 1 case(0.3%), and acute cerebral infarction in 1 case(0.3%). All patients recovered after symptomatic treatment. Univariate analysis showed that age, preoperative serum calcium, alkaline phosphatase and iPTH were significantly different(P<0.05). Multivariate analysis showed that age, preoperative serum calcium and iPTH were independent risk factors of severe hypocalcemia. Conclusion PTX is a safe and effective treatment for uremic refractory SHPT. Patients with low preoperative serum calcium, young age and high iPTH are prone to develop severe hypocalcemia after operation.

Key words: Secondary hyperparathyroidism, Parathyroidectomy, Severe hypocalcemia

CLC Number: 

  • R574
[1] 张建荣, 张凌. 慢性肾脏病继发性甲旁亢[M]. 北京: 人民军医出版社, 2010.
[2] Komaba H, Taniguchi M, Wada A, et al. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism [J]. Kidney Int, 2015, 88(2): 350-359.
[3] Goldsmith D, Kothawala P, Chalian A, et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD [J]. Am J Kidney Dis, 2009, 53(6): 1002-1013.
[4] Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study [J]. Clin J Am Soc Nephrol, 2015, 10(1): 98-109.
[5] National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease [J]. Am J Kidney Dis, 2003, 42( Suppl 3): 1-201.
[6] Fukagawa M, Yokoyama K, Koiwa F, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder [J]. Ther Apher Dial, 2013, 17(3): 247-288.
[7] 田文, 贺青卿, 姜可伟, 等. 慢性肾功能衰竭继发甲状旁腺功能亢进外科临床实践专家共识[J]. 中国实用外科杂志, 2016, 36(5): 481-486.
[8] 周鹏, 贺青卿, 庄大勇, 等. 甲状旁腺全切加微量甲状旁腺自体移植术在肾性甲状旁腺功能亢进中的临床应用[J]. 中华内分泌外科杂志, 2018, 12(1): 34-38. ZHOU Peng, HE Qingqing, ZHUANG Dayong, et al. Application of total parathyroidectomy with autotransplantation in secondary hyperparathyroidism [J]. Chinese Journal of Endocrine Surgery, 2018, 12(1): 34-38.
[9] 周鹏, 庄大勇, 贺青卿, 等. 达芬奇机器人甲状旁腺全切加部分腺体自体移植术治疗肾性甲状旁腺功能亢进[J]. 中华普通外科杂志, 2018, 33(1): 49-52. ZHOU Peng, ZHUANG Dayong, HE Qingqing, et al. Use of da Vinci Si surgical system in total parathyroidectomy with autotransplantation for secondary renal hyperparathyroidism [J]. Chinese Journal of General Surgery, 2018, 33(1): 49-52.
[10] Sun X, Zhang X, Lu Y, et al. Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism [J]. Sci Rep, 2018, 8(1): 7743.
[11] Tsai WC, Peng YS, Chiu YL, et al. Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism [J]. Int Urol Nephrol, 2015, 47(7): 1203-1207.
[12] Kidney Disease: Improving Global Outcomes(KDIGO)CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)[J]. Kidney International, 2009, 76(113): 1-130.
[13] Djukanovic L, Dimkovic N, Marinkovic J, et al. Association between hemodialysis patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism [J]. Nephron, 2016, 132(3): 168-174.
[14] Oliveira RB, Silva EN, Charpinel DM, et al. Secondary hyperparathyroidism status in Brazil: Brazilian census of parathyroidectomy [J]. J Bras Nefol, 2011, 33(4): 457-462.
[15] Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the kidney disease: Improving global outcomes 2017 clinical practice guideline Update [J]. Ann Intern Med, 2018, 168(6): 422-430.
[16] Wheeler DC, Winkelmayer AK, Abu-Alfa AK, et al. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)[J]. Kidney Int Suppl, 2017, 7(1): 1-59.
[17] 胡茂飞, 刘庆, 高新春, 等. 难治性SHPT治疗新理念:甲状旁腺肃清手术[J]. 中国现代普通外科进展, 2018, 21(8): 623-627.
[18] 胡茂飞, 林惠, 高新春, 等. TPTX与TPTX+AT治疗CKD患者SHPT预后的Meta分析[J]. 中国现代普通外科进展, 2018, 21(10): 783-790. HU Maofei, LIN Hui, GAO Xinchun, et al. Parathyroidectomy(TPTX versus TPTX+AT)for secondary hyperparathyroidism in chronic kidney disease: A Meta-Analysis [J]. Chinese Journal of Current Advances in General Surgery, 2018, 21(10): 783-790.
[19] Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism [J]. Clin J Am Soc Nephrol, 2018, 13(6): 952-961.
[20] Barczynski M, Golkowski F, Nawrot I. The current status of intraoperative iPTH assay in surgery for primary hyperparathyroidism [J]. Gland Surg, 2015, 4(1): 36-43.
[21] 刘新杰, 许楠, 蔡炜, 等. 术中甲状旁腺激素测定评判继发性甲状旁腺功能亢进手术成功的标准构想[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 65-70. LIU Xinjie, XU Nan, CAI Wei, et al. Conception of successive criterion of intraoperative parathyroid hormone assay during parathyroidectomy in secondary hyperparathyroidism [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2016, 30(2): 65-70.
[22] 陈安举, 王田田, 薄少军, 等. 术中甲状旁腺激素测定在继发性甲状旁腺功能亢进手术中的临床应用价值[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(12): 1168-1172. CHEN Anju, WANG Tiantian, BO Shaojun, et al. Clinical value of intraoperative parathyroid hormone determination in secondary hyperparathyroidism operation [J]. Journal of Clinical Otolaryngology Head and Neck Surgery, 2019, 33(12): 1168-1172.
[23] 张小会, 胡成进, 王延群. 甲状旁腺激素及其他生化指标在继发性甲状旁腺功能亢进手术中的应用[J]. 国际检验医学杂志, 2019, 40(17): 2128-2131. ZHANG Xiaohui, HU Chengjin, WANG Yanqun. Application of parathyroid hormone and other biochemical indicators in the surgery of secondary hyperparathyroidism [J]. International Journal of Laboratory Medical, 2019, 40(17): 2128-2131.
[24] Cheng SP, Lee JJ, Liu TP, et al. Parathyroidectomy improves symptomatology and quality of life in patients with secondary hyperparathyroidism [J]. Surgery, 2014, 155(2): 320-328.
[25] Ishani A, Liu J, Wetmore JB, et al. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis [J]. Clin J Am Soc Nephrol, 2015, 10(1): 90-97.
[26] Anwar F, Abraham J, Nakshabandi A, et al. Treatment of hypocalcemia in hungry bone syndrome: A case report [J]. Int J Surg Case Rep, 2018, 51: 335-339. doi: 10.1016/j.ijscr.2018.08.011.
[27] Ho LY, Wong PN, Sin HK, et al. Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism [J]. BMC Nephrol, 2017, 18(1): 12.
[28] Witteveen JE, van Thiel S, Romijn JA, et al. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature [J]. Eur J Endocrinol, 2013, 168(3): 45-53.
[29] 艾向南, 金昌国, 欧阳才国, 等. 继发性甲状旁腺功能亢进患者甲状旁腺切除术后重度低钙血症相关因素分析[J]. 滨州医学院学报, 2015, 38(4): 257-259. AI Xiangnan, JIN Changguo, OUYANG Caiguo, et al. Analysis of factors associated with severe hypocalcemia after parathyroidectomy for secondary hyperparathyroidism patients [J]. Journal of Binzhou Medical University, 2015, 38(4): 257-259.
[1] ZHANG Wei, TAN Wenhao, LI Yibin. Locmotion control of quadruped robot based on deep reinforcement learning: review and prospect [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 61-66.
[2] WU Qiang, HE Zekun, LIU Ju, CUI Xiaomeng, SUN Shuang, SHI Wei. A research on multi-modal MRI analysis based on machine learning for brain glioma [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 81-87.
[3] YIN Yilong, XI Xiaoming, MENG Xianjing. Intelligent diagnosis methods of Alzheimers disease [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 14-21.
[4] LIU Ju, WU Qiang, YU Luyue, LIN Fengming. Brain tumor image segmentation based on deep learning techniques [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 42-49.
[5] . [J]. Journal of Shandong University (Health Sciences), 2020, 58(8): 120-122.
[6] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury [J]. Journal of Shandong University (Health Sciences), 2020, 58(7): 1-6.
[7] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice [J]. Journal of Shandong University (Health Sciences), 2020, 58(7): 7-14.
[8] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer [J]. Journal of Shandong University (Health Sciences), 2020, 58(7): 47-52.
[9] JI Yongjuan, XIANG Zini, KUANG Guifang. A path analysis on the influence of burnout on quality of life among staff in two tertiary hospitals in Qingdao [J]. Journal of Shandong University (Health Sciences), 2020, 58(7): 102-107.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd